Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mitoxantrone (novantrone) (1 trial)
Autoimmune Diseases (Phase 4)
Autoimmune Diseases of the Nervous System (Phase 4)
Demyelinating Autoimmune Diseases, CNS (Phase 4)
Myelitis (Phase 4)
Myelitis, Transverse (Phase 4)
Nervous System Diseases (Phase 4)
Neuromyelitis Optica (Phase 4)
Trials (1 total)
Trial APIs (1 total)